Intercalated Erlotinib-Docetaxel Dosing Schedules Designed to Achieve Pharmacodynamic Separation: Results of a Phase I/II Trial-Reference-Cited by-同舟云学术

Intercalated Erlotinib-Docetaxel Dosing Schedules Designed to Achieve Pharmacodynamic Separation: Results of a Phase I/II Trial

Published:2011-12 Issue:12 Volume:6 Page:2112-2119
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Sangha Randeep,Davies Angela M.,Lara Primo N.,Mack Philip C.,Beckett Laurel A.,Hesketh Paul J.,Lau Derick,Li Tianhong,Perkins Natasha,Gandara David R.

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference27 articles.

1. Erlotinib in previously treated non-small-cell lung cancer;Shepherd;N Engl J Med,2005

2. Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy;Shepherd;J Clin Oncol,2000

3. Gefitinib in combination with gemcitabine and cisplatin in advanced non-small-cell lung cancer: a phase III trial–INTACT 1;Giaccone;J Clin Oncol,2004

4. Gefitinib in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer: a phase III trial–INTACT 2;Herbst;J Clin Oncol,2004

5. TRIBUTE: a phase III trial of erlotinib hydrochloride (OSI-774) combined with carboplatin and paclitaxel chemotherapy in advanced non-small-cell lung cancer;Herbst;J Clin Oncol,2005

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current status and frontier tracking of clinical trials on Metformin for cancer treatment;Journal of Cancer Research and Clinical Oncology;2023-09-12

2. Randomized phase III study of docetaxel versus docetaxel plus intercalated erlotinib in patients with relapsed non-squamous non-small cell lung carcinoma;Lung Cancer;2021-10

3. Induction therapy with Erlotinib (E) and Gemcitabine/Platinum (GP) in stage III NSCLC;Journal of Pulmonology and Respiratory Research;2021-01-28

4. Phase I/II study of intermitted erlotinib in combination with docetaxel in patients with recurrent non-small cell lung cancer (WJOG4708L);Japanese Journal of Clinical Oncology;2019-06-26

5. Serum Concentration of Erlotinib and its Correlation with Outcome and Toxicity in Patients with Advanced-stage NSCLC;Anticancer Research;2017-10-23